Super-vaccine trial for coronaviruses set for 2025

healthpolicy-watch.news

Researchers have developed an all-in-one coronavirus vaccine to combat various strains, including unknown ones. Published in Nature Nanotechnology, the vaccine, tested successfully on mice, is set for human trials in early 2025. The vaccine's key component is a chain of receptor-binding-domains from different coronaviruses. This proactive vaccinology approach aims to swiftly respond to potential pandemics. The vaccine offers broad immunity, even against unanticipated coronaviruses.


With a significance score of 4.9, this news ranks in the top 2.1% of today's 29164 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Super-vaccine trial for coronaviruses set for 2025 | News Minimalist